MicroRNA‐221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling

Yingchun Yin(Central Hospital of Zibo), Ziqiang Zhou(Central Hospital of Zibo)
Cancer Medicine
January 3, 2020
Cited by 46


Related Papers